Partnership with OMRON HEALTHCARE and making OMRON COLIN a subsidiary
First written in FY2016. 6 of 9 entries say "Restated". Latest entry: FY2018.
No other company in this theme has enough history to compare yet.
- FY2018Cited as achievedAnnual report
「Regarding the Group’s operating results for the consolidated fiscal year under review, revenue was ¥128,883 million, up 5.9% year on year, owing to the strengthening of the core domestic business and the effects of the acquisition of フクダコーリン.」
The completed acquisition of フクダコーリン is cited as one of the factors behind revenue growth in the year under review. - FY2018-Q3RestatedAnnual report
「Revenue increased, partly because フクダコーリン㈱ was added to the consolidated group.」
The addition of フクダコーリン㈱, formerly OMRON COLIN, to the consolidated group is reaffirmed as a factor behind revenue growth in the biological testing equipment segment. - FY2018-Q2RestatedAnnual report
「Revenue increased, partly because フクダコーリン㈱ was added to the consolidated group.」
The addition of フクダコーリン㈱ to the consolidated group is reaffirmed as a factor behind revenue growth in the biological testing equipment segment. - FY2018-Q1RestatedAnnual report
「Revenue increased, partly because フクダコーリン㈱ was added to the consolidated group.」
After OMRON COLIN became a wholly owned subsidiary, the addition of フクダコーリン㈱ to the consolidated group was cited as a factor behind revenue growth in the biological testing equipment segment. - FY2017RestatedAnnual report
「The acquisition of the shares was completed on 1 December 2016. As a result, the company became a wholly owned subsidiary of the Company.」
The completion of the acquisition of OMRON COLIN and its conversion into a wholly owned subsidiary are also confirmed in the annual report. - FY2017-Q3AdvancedAnnual report
「Because OMRON COLIN Co., Ltd.〔whose corporate name was changed to フクダコーリン株式会社 effective 1 January 2017〕 became a wholly owned subsidiary during the third quarter of the consolidated fiscal year, it was included in the scope of consolidation.」
The acquisition of the shares was completed on 1 December 2016, making the company a wholly owned subsidiary with a 100% voting interest and completing its inclusion in the scope of consolidation. - FY2017-Q2RestatedAnnual report
「FUKUDA DENSHI CO.,LTD. and OMRON Healthcare reached a memorandum of basic agreement for a business partnership under which they would mutually leverage their respective strengths to respond rapidly to changes in the market environment, create new businesses in fields including home healthcare, and accelerate global business expansion. As part of the partnership, FUKUDA DENSHI CO.,LTD. would acquire shares in OMRON COLIN, which operates an in-hospital medical equipment business, to further strengthen its own in-hospital medical equipment business.」
The objectives of the partnership, namely creating new businesses in home healthcare, expanding the overseas business, and strengthening the in-hospital medical equipment business, are restated. The closing date for the share transfer of OMRON COLIN remained undecided. - FY2017-Q1RestatedAnnual report
「FUKUDA DENSHI CO.,LTD. and OMRON Healthcare reached a memorandum of basic agreement for a business partnership under which they would mutually leverage their respective strengths to respond rapidly to changes in the market environment, create new businesses in fields including home healthcare, and accelerate global business expansion. As part of the partnership, FUKUDA DENSHI CO.,LTD. would acquire shares in OMRON COLIN, which operates an in-hospital medical equipment business, to further strengthen its own in-hospital medical equipment business.」
The objectives of the partnership, namely creating new businesses in home healthcare, expanding the overseas business, and strengthening the in-hospital medical equipment business, are described in detail, but the closing date for the share transfer remained undecided, making this a restatement of the existing plan. - FY2016First statedAnnual report
「FUKUDA DENSHI CO.,LTD. and OMRON Healthcare Co., Ltd. entered into a memorandum of basic agreement for a business partnership in the home healthcare and overseas business fields, as well as a share transfer agreement under which OMRON Healthcare would transfer its shares in OMRON COLIN Co., Ltd. to FUKUDA DENSHI CO.,LTD., making OMRON COLIN a subsidiary. The agreements were signed on 9 June 2016.」
The memorandum of basic agreement and share transfer agreement had been signed. The stated acquisition price for OMRON COLIN was ¥2 billion, with an ownership ratio of voting rights of 100% after the acquisition; the closing date for the share transfer had not yet been determined.